Publications by authors named "R Grinberg"
BACKGROUND Many patients experiencing acute coronary syndrome (ACS) present in cardiac arrest. Mechanical chest compressions are a common tool in cardiopulmonary resuscitation (CPR) and have their benefits as well as disadvantages and reported complications. In recent years, veno-arterial extracorporeal oxygenation membrane (VA-ECMO) has proven to be a promising tool in these circumstances and is now considered part of the treatment algorithm in emergent and refractory cases.
View Article and Find Full Text PDFArticle Synopsis
- - The DES-OSA score helps predict obstructive sleep apnea syndrome (OSAS) severity by using physical examination signs, and this study validated its effectiveness in the Israeli population.
- - Researchers conducted a study with 106 patients, finding high correlation between DES-OSA scores and actual sleep apnea severity, and strong agreement between two physicians calculating the scores.
- - The results showed that a DES-OSA score of 5 or lower could effectively rule out moderate to severe OSAS, and adding age over 66 years improved the scoring sensitivity.
Article Synopsis
- Atrial fibrillation is a common heart arrhythmia treated through ablation, a procedure that carries risks, including a rare but fatal complication known as atrio-esophageal fistula.
- Two patients, a 67-year-old man and a 64-year-old woman with preexisting health issues, developed this complication about six weeks after undergoing radiofrequency ablation and presented with severe symptoms that rapidly worsened.
- Prompt recognition of symptoms like fever, neurological deficits, and gastrointestinal bleeding is crucial, as untreated atrio-esophageal fistula can lead to death, and early diagnosis is essential for potential treatment interventions.
One-to-one laptop initiatives have become prevalent in schools aiming to enhance active learning and assist students in developing twenty-first-century skills. This paper reports on a qualitative investigation of teachers in a junior high school in Northern Israel, who were gradually implementing one-to-one computing. The research reported in this paper is based on longitudinal data collected over a five-year period and included all of the teachers who participated in the project.
View Article and Find Full Text PDFArticle Synopsis
- Scientists studied how some lung cancer patients stopped responding to a drug called osimertinib that they took first, compared to when they took it second.
- They looked at 30 patients' tumor tests and found that almost all of them kept their main cancer change (EGFR mutation), but a different change (C797S) happened more in patients who took the drug second.
- The study also tested different treatments after the drug stopped working and found that combining treatments helped patients live longer, with survival times ranging from 12 to 80 months.